Boston Scientific Corporation is facing significant challenges as it navigates a 53% drop in stock price following robust earnings reports and a Class I recall of its AXIOS Stent and Electrocautery-Enhanced Delivery Systems. Despite achieving a 15.9% revenue growth in the last quarter, reaching $5.29 billion, investor confidence has waned amidst the company's recent $11 billion financing arrangement for the acquisition of Penumbra. While an anticipated EPS rise to $0.79 may hint at potential stabilization, the overall market performance remains turbulent with the stock trading well below its 50-day and 200-day moving averages.
“Boston Scientific Corp. · has volume · 2,022,429 · 2,022,429”
“Boston Scientific (BSX) · ended the recent trading session at · $76.85 · +1.45% change from the preceding day's closing price”
“Boston Scientific (BSX) · shares have depreciated by · 17.96% · over the course of the past month”
“Boston Scientific (BSX) · is anticipated to report an EPS of · $0.79 · marking a 5.33% rise compared to the same quarter of the previous year”
“Boston Scientific · is currently a Zacks Rank · #3 · (Hold)”
“BSX · holds a PEG ratio of · 1.05 · bears resemblance to the frequently used P/E ratio”
“Boston Scientific · announced · Class I recall of AXIOS Stent and Electrocautery-Enhanced Delivery Systems · due to deployment complications linked to serious injuries and deaths”
“Boston Scientific · arranged · US$11b in new financing · to support its pending acquisition of Penumbra”
“Boston Scientific Corporation (NYSE:BSX) · is one of the best · strong buy healthcare stocks · to invest in”
“Boston Scientific Corporation (NYSE:BSX) · announced · the election of Cathy Smith and Christophe Weber · to its Board of Directors, effective February 18, 2026”
“Boston Scientific Corporation (NYSE:BSX) · received · several rating updates · following its fiscal Q4 and full-year earnings release”
“Boston Scientific Corporation (NYSE:BSX) · reported · net sales of $5.286 billion during fiscal Q4 · reflecting a 15.9% growth compared to the prior year period”